Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 14;58(19):8264-8277.
doi: 10.1021/acs.est.4c00094. Epub 2024 May 1.

Cross-Sectional Associations between Prenatal Per- and Poly-Fluoroalkyl Substances and Bioactive Lipids in Three Environmental Influences on Child Health Outcomes (ECHO) Cohorts

Affiliations

Cross-Sectional Associations between Prenatal Per- and Poly-Fluoroalkyl Substances and Bioactive Lipids in Three Environmental Influences on Child Health Outcomes (ECHO) Cohorts

Himal Suthar et al. Environ Sci Technol. .

Abstract

Prenatal per- and poly-fluoroalkyl substances (PFAS) exposure may influence gestational outcomes through bioactive lipids─metabolic and inflammation pathway indicators. We estimated associations between prenatal PFAS exposure and bioactive lipids, measuring 12 serum PFAS and 50 plasma bioactive lipids in 414 pregnant women (median 17.4 weeks' gestation) from three Environmental influences on Child Health Outcomes Program cohorts. Pairwise association estimates across cohorts were obtained through linear mixed models and meta-analysis, adjusting the former for false discovery rates. Associations between the PFAS mixture and bioactive lipids were estimated using quantile g-computation. Pairwise analyses revealed bioactive lipid levels associated with PFDeA, PFNA, PFOA, and PFUdA (p < 0.05) across three enzymatic pathways (cyclooxygenase, cytochrome p450, lipoxygenase) in at least one combined cohort analysis, and PFOA and PFUdA (q < 0.2) in one linear mixed model. The strongest signature revealed doubling in PFOA corresponding with PGD2 (cyclooxygenase pathway; +24.3%, 95% CI: 7.3-43.9%) in the combined cohort. Mixture analysis revealed nine positive associations across all pathways with the PFAS mixture, the strongest signature indicating a quartile increase in the PFAS mixture associated with PGD2 (+34%, 95% CI: 8-66%), primarily driven by PFOS. Bioactive lipids emerged as prenatal PFAS exposure biomarkers, deepening insights into PFAS' influence on pregnancy outcomes.

Keywords: PFAS; bioactive lipids; eicosanoids; inflammatory pathways; metabolic pathways; mixtures; pregnancy outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Heatmap of β estimates corresponding to percentage change in bioactive lipids as a result of doubling log-transformed PFAS for adjusted joint analyses and meta-analyses run on adjusted within-cohort models. The magnitude of effect estimates in each cell in the heatmap corresponds to the intensity of the color band in the legend. Nonsignificant values (p > .05) are marked with black “X”. Sample sizes range from 343 to 383 (see Supplemental Tables 7, 8, 9, and 10 for exact pairwise sample sizes).
Figure 2
Figure 2
Forest plot of quantile g-computation effect estimates in the combined cohort analysis with IKIDS and CIOB cohorts (N = 343), showing of β estimates corresponding to percentage change in bioactive lipids associated with a simultaneous 1-quartile increase in all log-transformed PFAS. Model adjusted for maternal age, maternal education, prepregnancy BMI, parity, gestational age at visit, and cohort.

Update of

References

    1. Sunderland E. M.; Hu X. C.; Dassuncao C.; Tokranov A. K.; Wagner C. C.; Allen J. G. A Review of the Pathways of Human Exposure to Poly-and Perfluoroalkyl Substances (PFASs) and Present Understanding of Health Effects. J. Exposure Sci. Environ. Epidemiol. 2019, 29 (2), 131–147. 10.1038/s41370-018-0094-1. - DOI - PMC - PubMed
    1. Calafat A. M.; Wong L.-Y.; Kuklenyik Z.; Reidy J. A.; Needham L. L. Polyfluoroalkyl Chemicals in the US Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000. Environ. Health Perspect. 2007, 115 (11), 1596–1602. 10.1289/ehp.10598. - DOI - PMC - PubMed
    1. Chiu W. A.; Lynch M. T.; Lay C. R.; Antezana A.; Malek P.; Sokolinski S.; Rogers R. D. Bayesian Estimation of Human Population Toxicokinetics of PFOA, PFOS, PFHxS, and PFNA from Studies of Contaminated Drinking Water. Environ. Health Perspect. 2022, 130 (12), 12700110.1289/EHP10103. - DOI - PMC - PubMed
    1. Fenton S. E.; Ducatman A.; Boobis A.; DeWitt J. C.; Lau C.; Ng C.; Smith J. S.; Roberts S. M. Per-and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research. Environ. Toxicol. Chem. 2021, 40 (3), 606–630. 10.1002/etc.4890. - DOI - PMC - PubMed
    1. Calafat A. M.; Wong L.-Y.; Kuklenyik Z.; Reidy J. A.; Needham L. L. Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000. Environ. Health Perspect. 2007, 115 (11), 1596–1602. 10.1289/ehp.10598. - DOI - PMC - PubMed